0:005:48

Computer modeling of new drugs

HANNA KARPENKA 5:48 2021

Two times faster, six times cheaper: modeling drug candidates before the lab

A screening pipeline that starts with a protein structure and ends with a ranked list of compounds worth synthesising: Hanna Karpenka, team leader of the Drug Design Group at Belarus's United Institute of Informatics Problems, says it runs at least two times faster and six times cheaper than classical discovery. Her group has already flagged candidate inhibitors of the SARS-CoV-2 main protease. Where exactly do neural networks enter the chain?

See the five-step pipeline that turns a protein target into testable drug candidates

Watch on YouTube

In short

Hanna Karpenka presents how her computational drug design team turns a known biological target into a ranked list of compounds worth synthesising, using pharmacophore models, virtual screening, molecular dynamics and neural networks. She walks through the group's five-step workflow, its published COVID-19 results and the kinds of research collaboration it is looking for. Her argument is that a theoretical, computer-first approach cuts both the time and the cost of early drug discovery.

“As you can see, I and my team are professional from various benches of science such as chemistry, computer science, biology, mathematics and physics.”
“On the next step, we use obtain results as a teaching dataset for our neural network and generate more potential active compounds.”

What you will learn

  • Follow a five-step computational workflow from biological target to candidate compound list
  • Spot where neural networks add value in early-stage discovery and where classical methods still decide
  • Compare the time and cost of computer-aided screening with laboratory-first discovery
  • Understand what a known, deposited protein structure makes possible for a modeling team
  • Plan a research collaboration around joint projects, publications and patents

Key takeaways from the speaker

  • bioinformatics
  • drug design
  • ML

Details

Level
Intermediate
Format
Lightning talk
Technical depth
Introductory technical
For
Early career, Mid-career, Senior individual contributor
Length
5:48
Published
June 2021

Questions this talk answers

What are the steps in the team's computer-aided drug discovery workflow?

A target is chosen, a pharmacophore model is reconstructed and virtual screening is run, identified compounds are sorted with molecular modeling tools, and those results become a training dataset for a neural network that generates more potential active compounds. The best compounds are then evaluated with molecular dynamics and quantum chemistry tools, which the speaker says give the most reliable results.

Where do neural networks fit into the process today?

The speaker says neural networks can in principle be used at every step, and distinguishes on her diagram the green part the team already does from the blue part it expects to add.

How much time and money does the computational approach save?

Because the approach is theoretical, it is less cost and time demanding: at least two times faster and six times cheaper than the classical approach, as the speaker states.

What does a team need before it can model a disease target?

The group can work on any disease whose biological trigger is known and deposited in the Protein Data Bank.

What is the end product of the work?

A list of potential inhibitors for a certain biological target, with detailed information about their activity, ready for laboratory testing in vitro and in vivo.

About this talk

omputer molecular modeling techniques play an important role in research into the development of new drugs. The use of neural networks for these methods in the rational design of potential drugs can minimize the time and cost of searching for various targets and potential drugs! Such a computer model can, with high probability, predict the vulnerability in the structure of the infectious agent and indicate which chemical compound should be synthesized.

Topics

Related talks

Browse the library